Estrogen receptors in hip joint capsule and ligamentum capitis femoris of babies with developmental dysplasia of the hip. 2013

Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
Department of Orthopedics and Traumatology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Turkey. erendesteli@yahoo.co.uk

OBJECTIVE The aim of this study was to detect the incidence of estrogen receptors in human hip joint capsule and ligamentum teres. METHODS The study included biopsies of the ligamentum capitis femoris (LCF) and hip joint capsule from 15 patients undergoing hip surgery for developmental dysplasia of the hip (DDH) and from the control hips of 15 cases of intrauterine fetal death. Mean age was 10.3 (range: 6 to 18) months at the time of surgery. Full-thickness 1x1 cm anterior capsule and LCF portions were taken as biopsy specimens. An immunohistochemical study using monoclonal antibody against estrogen receptors was performed to identify the rate of target estrogen cells in the hip joint capsule and LCF. RESULTS Estrogen receptor (ER) staining rates were 1.6±0.2% for the LCF and 1.3±0.2% for the hip joint capsule in the control groups, and 2.5±0.3% for the LCF and 2.0±0.3% for the hip joint capsule in the DDH groups. Estrogen receptor staining rates in the LCF and hip joint capsule control groups were significantly lower than that in the DDH groups (p<0.001). In both groups, ER rates were significantly lower in the hip joint capsule than in the LCF (p<0.01). CONCLUSIONS The high rate of ERs in the LCF and hip joint capsule appears to support the effect of estrogen in the etiology of the DDH.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D007223 Infant A child between 1 and 23 months of age. Infants
D008023 Ligaments, Articular Fibrous cords of CONNECTIVE TISSUE that attach bones to each other and hold together the many types of joints in the body. Articular ligaments are strong, elastic, and allow movement in only specific directions, depending on the individual joint. Articular Ligament,Articular Ligaments,Ligament, Articular
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal
D006618 Hip Dislocation, Congenital Congenital dislocation of the hip generally includes subluxation of the femoral head, acetabular dysplasia, and complete dislocation of the femoral head from the true acetabulum. This condition occurs in approximately 1 in 1000 live births and is more common in females than in males. Hip Dysplasia, Congenital,Congenital Dysplasia Of The Hip,Congenital Hip Dislocation,Congenital Hip Displacement,Congenital Hip Dysplasia,Dislocation Of Hip, Congenital,Dislocation, Congenital Hip,Displacement, Congenital Hip,Dysplasia, Congenital Hip,Hip Displacement, Congenital,Hip Dysplasia, Congenital, Nonsyndromic,Hip, Dislocation Of, Congenital,Congenital Hip Dislocations,Congenital Hip Displacements,Congenital Hip Dysplasias,Dislocations, Congenital Hip,Displacements, Congenital Hip,Dysplasias, Congenital Hip,Hip Dislocations, Congenital,Hip Displacements, Congenital,Hip Dysplasias, Congenital

Related Publications

Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
September 2004, Journal of pediatric orthopedics. Part B,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
September 2007, Journal of pediatric orthopedics. Part B,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
March 2003, Journal of the South African Veterinary Association,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
January 1967, Orizzonti della ortopedia odierna e della riabilitazione,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
October 2000, Acta orthopaedica Scandinavica,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
January 2021, Acta orthopaedica et traumatologica turcica,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
March 2013, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
December 1989, Ortopediia travmatologiia i protezirovanie,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
July 1971, Zeitschrift fur Orthopadie und ihre Grenzgebiete,
Engin Eren Desteli, and Ahmet Pişkin, and Ahmet Birol Gülman, and Figen Kaymaz, and Bülent Köksal, and Murat Erdoğan
May 1997, Journal of the American Veterinary Medical Association,
Copied contents to your clipboard!